Clinical trials in Australia – why, with whom, how to start?

Advertisement - in cooperation with Resolian and  Pathios Therapeutics

Clinical trials are becoming increasingly complex – requiring more integrated, cross-border approaches. In multiple recent expert roundtables discussions it became apparent that both the Australian and German ecosystems stand to benefit significantly from deeper collaboration. The session will provide insights from the discussions in a condensed manner – giving answers to 3 key questions that are relevant to decision makers when choosing partners for clinical trials.  Quality, Speed and Value are embedded in the Australian clinical trial ecosystem.